SI3380467T1 - Heterociklični indoli za uporabo v okužbi z virusom gripe - Google Patents

Heterociklični indoli za uporabo v okužbi z virusom gripe

Info

Publication number
SI3380467T1
SI3380467T1 SI201631276T SI201631276T SI3380467T1 SI 3380467 T1 SI3380467 T1 SI 3380467T1 SI 201631276 T SI201631276 T SI 201631276T SI 201631276 T SI201631276 T SI 201631276T SI 3380467 T1 SI3380467 T1 SI 3380467T1
Authority
SI
Slovenia
Prior art keywords
influenza virus
virus infection
indoles
heterocyclic
heterocyclic indoles
Prior art date
Application number
SI201631276T
Other languages
English (en)
Inventor
Tim Hugo Maria Jonckers
Gowan David Craig Mc
Jerome Emile Georges Guillemont
Ludwig Paul Cooymans
Werner Constant Johan Embrechts
Christophe Francis Robert Nestor Buyck
Wendy Mia Albert Balemans
Pierre Jean-Marie Bernard Raboisson
Original Assignee
Janssen Sciences Ireland Unlimited Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Sciences Ireland Unlimited Company filed Critical Janssen Sciences Ireland Unlimited Company
Publication of SI3380467T1 publication Critical patent/SI3380467T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
SI201631276T 2015-11-27 2016-11-25 Heterociklični indoli za uporabo v okužbi z virusom gripe SI3380467T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15196811 2015-11-27
PCT/EP2016/078778 WO2017089518A1 (en) 2015-11-27 2016-11-25 Heterocyclic indoles for use in influenza virus infection
EP16801246.6A EP3380467B1 (en) 2015-11-27 2016-11-25 Heterocyclic indoles for use in influenza virus infection

Publications (1)

Publication Number Publication Date
SI3380467T1 true SI3380467T1 (sl) 2021-08-31

Family

ID=54707665

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201631276T SI3380467T1 (sl) 2015-11-27 2016-11-25 Heterociklični indoli za uporabo v okužbi z virusom gripe

Country Status (16)

Country Link
US (1) US10626108B2 (sl)
EP (1) EP3380467B1 (sl)
JP (1) JP6903658B2 (sl)
KR (1) KR20180087290A (sl)
CN (1) CN108290869B (sl)
AU (1) AU2016359907B2 (sl)
CA (1) CA3005514A1 (sl)
DK (1) DK3380467T3 (sl)
EA (1) EA201891278A1 (sl)
ES (1) ES2882671T3 (sl)
HR (1) HRP20211223T1 (sl)
HU (1) HUE055200T2 (sl)
LT (1) LT3380467T (sl)
MA (1) MA43298A (sl)
SI (1) SI3380467T1 (sl)
WO (1) WO2017089518A1 (sl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ619259A (en) 2009-06-17 2015-07-31 Vertex Pharma Inhibitors of influenza viruses replication
UA118010C2 (uk) 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
MA42422A (fr) 2015-05-13 2018-05-23 Vertex Pharma Inhibiteurs de la réplication des virus de la grippe
JP6704416B2 (ja) 2015-05-13 2020-06-03 バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated インフルエンザウイルスの複製の阻害剤を調製する方法
LT3405466T (lt) 2016-01-20 2021-01-25 Janssen Sciences Ireland Unlimited Company Arilu pakeistieji pirimidinai, skirti naudoti gripo viruso infekcijos atveju
US10501444B2 (en) 2016-08-16 2019-12-10 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication, application methods and uses thereof
US10647693B2 (en) 2016-08-30 2020-05-12 North & South Brother Pharmacy Investment Company Limited Inhibitors of influenza virus replication, application methods and uses thereof
WO2018108125A1 (en) 2016-12-15 2018-06-21 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication and uses thereof
JP7299837B2 (ja) * 2016-12-23 2023-06-28 アクイナ ファーマシューティカルズ, インコーポレイテッド 化合物、組成物、および使用方法
US11098042B2 (en) 2017-01-05 2021-08-24 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication and uses thereof
CN110446711B (zh) 2017-03-02 2022-02-15 广东东阳光药业有限公司 流感病毒复制抑制剂及其用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ567133A (en) 2005-09-30 2011-07-29 Vertex Pharma Deazapurines useful as inhibitors of janus kinases
CA2659582A1 (en) * 2006-06-22 2007-12-27 Merck & Co., Inc. Tyrosine kinase inhibitors
RU2481340C2 (ru) 2007-02-08 2013-05-10 Тиботек Фармасьютикалз Лтд. Пиримидин-замещенные макроциклические ингибиторы hcv
NZ619259A (en) 2009-06-17 2015-07-31 Vertex Pharma Inhibitors of influenza viruses replication
ES2602972T3 (es) 2010-09-08 2017-02-23 Glaxosmithkline Intellectual Property Development Limited Derivados de indazol para su uso en el tratamiento de infección por virus de la gripe
CN103562205A (zh) * 2010-12-16 2014-02-05 沃泰克斯药物股份有限公司 流感病毒复制的抑制剂
JP2013545816A (ja) 2010-12-16 2013-12-26 バーテックス ファーマシューティカルズ インコーポレイテッド インフルエンザウイルス複製阻害物質
ES2691745T3 (es) 2011-04-08 2018-11-28 Janssen Sciences Ireland Uc Derivados de pirimidina para el tratamiento de infecciones víricas
UA118010C2 (uk) 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
EP2858984A1 (en) 2012-06-08 2015-04-15 Vertex Pharmaceuticals Inc. Inhibitors of influenza viruses replication
ME02835B (me) 2012-10-16 2018-01-20 Janssen Sciences Ireland Uc Antivirusna rsv jedinjenja
JP6404835B2 (ja) 2013-02-21 2018-10-17 ヤンセン・サイエンシズ・アイルランド・ユーシー ウイルス感染の治療のための2−アミノピリミジン誘導体
LT3405466T (lt) 2016-01-20 2021-01-25 Janssen Sciences Ireland Unlimited Company Arilu pakeistieji pirimidinai, skirti naudoti gripo viruso infekcijos atveju

Also Published As

Publication number Publication date
LT3380467T (lt) 2021-08-10
JP2019501879A (ja) 2019-01-24
KR20180087290A (ko) 2018-08-01
EA201891278A1 (ru) 2018-11-30
AU2016359907B2 (en) 2021-04-01
DK3380467T3 (da) 2021-09-27
MA43298A (fr) 2021-04-14
US20180258074A1 (en) 2018-09-13
WO2017089518A1 (en) 2017-06-01
HUE055200T2 (hu) 2021-11-29
AU2016359907A1 (en) 2018-05-24
CN108290869A (zh) 2018-07-17
US10626108B2 (en) 2020-04-21
EP3380467A1 (en) 2018-10-03
EP3380467B1 (en) 2021-07-07
JP6903658B2 (ja) 2021-07-14
CN108290869B (zh) 2021-05-18
CA3005514A1 (en) 2017-06-01
ES2882671T3 (es) 2021-12-02
HRP20211223T1 (hr) 2021-11-12

Similar Documents

Publication Publication Date Title
ZA201700952B (en) Indoles for use in influenza virus infection
LT3380467T (lt) Heterocikliniai indolai, skirti naudoti gripo viruso infekcijų atveju
ZA201701643B (en) Pyrrolopyrimidines for use in influenza virus infection
HK1247611A1 (zh) 作為登革熱病毒複製抑制劑的吲哚衍生物
HUE053078T2 (hu) Aril-szubsztituált pirimidinek influenza vírus fertõzésben való alkalmazásra
GB201406608D0 (en) Virus
HRP20180639T1 (hr) Derivati izoindolina, namijenjeni upotrebi u liječenju virusne infekcije
GB201419572D0 (en) Virus
HK1243705A1 (zh) 吲哚衍生物
GB201522013D0 (en) Virus
GB201600380D0 (en) Modified virus
GB201516936D0 (en) Virus
GB201507419D0 (en) Virus
GB201406470D0 (en) Virus
GB201408046D0 (en) Virus preparations
GB201403582D0 (en) Virus
TH1501007823A (th) วิธีการเเละองค์ประกอบสำหรับวัคซีนเดงกีไวรัส
AU2014900488A0 (en) Agents and methods for inhibiting virus infection